Published in Am J Med on September 16, 2010
Lack of exercise is a major cause of chronic diseases. Compr Physiol (2012) 2.19
Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98
Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? World J Gastroenterol (2012) 0.96
Phenotypic and molecular differences between rats selectively bred to voluntarily run high vs. low nightly distances. Am J Physiol Regul Integr Comp Physiol (2013) 0.93
Physical activity and modernization among Bolivian Amerindians. PLoS One (2013) 0.91
The great outdoors: how a green exercise environment can benefit all. Extrem Physiol Med (2013) 0.91
The Health at Every Size paradigm and obesity: missing empirical evidence may help push the reframing obesity debate forward. Am J Public Health (2015) 0.81
Natural environments, ancestral diets, and microbial ecology: is there a modern "paleo-deficit disorder"? Part II. J Physiol Anthropol (2015) 0.77
Monitoring fitness levels and detecting implications for health in a French population: an observational study. BMJ Open (2012) 0.75
Gender comparisons of physical fitness indexes in Inner Mongolia medical students in China. Glob J Health Sci (2014) 0.75
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 5.27
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol (2004) 4.07
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus. Am J Cardiol (2012) 2.77
Omega-3 fatty acids for cardioprotection. Mayo Clin Proc (2008) 2.65
Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol (2013) 2.62
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am Heart J (2008) 2.61
Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol (2007) 2.52
Run for your life ... at a comfortable speed and not too far. Heart (2012) 2.48
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc (2013) 2.10
Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98
Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc (2009) 1.88
Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer. Mayo Clin Proc (2004) 1.84
Physical activity promotion in the health care system. Mayo Clin Proc (2013) 1.83
Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol (2003) 1.80
Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc (2010) 1.75
Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology (2008) 1.71
EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation (2012) 1.67
Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol (2012) 1.61
Intensive lipid intervention in the post-ENHANCE era. Mayo Clin Proc (2008) 1.55
Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J (2013) 1.53
Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J (2008) 1.50
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev (2012) 1.47
The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv (2009) 1.47
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol (2002) 1.46
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel? Cardiology (2013) 1.44
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol (2004) 1.44
Stopping stress at its origins. Hypertension (2007) 1.44
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Evolutionary health promotion. Prev Med (2002) 1.41
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant (2009) 1.41
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol (2013) 1.37
The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37
A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol (2011) 1.33
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol (2006) 1.32
Dietary sodium restriction: take it with a grain of salt. Am J Med (2013) 1.30
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol (2003) 1.24
Superresolution optical fluctuation imaging with organic dyes. Angew Chem Int Ed Engl (2010) 1.24
Achieving increased resolution and more pixels with Superresolution Optical Fluctuation Imaging (SOFI). Opt Express (2010) 1.24
Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol (2009) 1.23
Evolutionary health promotion: a consideration of common counterarguments. Prev Med (2002) 1.21
45-Year trends in women's use of time and household management energy expenditure. PLoS One (2013) 1.21
Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr (2008) 1.20
Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc (2012) 1.18
Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLoS One (2008) 1.18
African hominin stable isotopic data do not necessarily indicate grass consumption. Proc Natl Acad Sci U S A (2013) 1.16
Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med (2009) 1.15
Simultaneous size and ζ-potential measurements of individual nanoparticles in dispersion using size-tunable pore sensors. ACS Nano (2012) 1.14
Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J (2004) 1.12
Tunable pores for measuring concentrations of synthetic and biological nanoparticle dispersions. Biosens Bioelectron (2011) 1.11
Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr (2010) 1.11
The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc (2012) 1.11
Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc (2006) 1.10
Maternal inactivity: 45-year trends in mothers' use of time. Mayo Clin Proc (2013) 1.10
Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 1.10
Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant (2006) 1.10
The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med (2008) 1.09
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc (2013) 1.09
Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr (2005) 1.08
The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc (2009) 1.08
Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J (2002) 1.07
Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs. Am J Cardiol (2009) 1.06
Of mice and men: atrial fibrillation in veteran endurance runners. J Am Coll Cardiol (2013) 1.06
Validation of a novel protocol for calculating estimated energy requirements and average daily physical activity ratio for the US population: 2005-2006. Mayo Clin Proc (2013) 1.05
A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev (2013) 1.05
The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev (2008) 1.04
Tunable nano/micropores for particle detection and discrimination: scanning ion occlusion spectroscopy. Small (2010) 1.04
T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks. Elife (2014) 1.02
Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert Rev Respir Med (2011) 0.99
Advances in Resistive Pulse Sensors: Devices bridging the void between molecular and microscopic detection. Nano Today (2011) 0.99
EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J (2012) 0.99
Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus. Circulation (2008) 0.98
The obesity paradox and outcome in heart failure: is excess bodyweight truly protective? Future Cardiol (2010) 0.97
Implementing alcohol screening and intervention in a family medicine residency clinic. Subst Abus (2005) 0.97
Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation (2004) 0.97
Cardiopulmonary exercise testing: relevant but underused. Postgrad Med (2010) 0.97
Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction. Mayo Clin Proc (2011) 0.96
Scientific decision making, policy decisions, and the obesity pandemic. Mayo Clin Proc (2013) 0.95
Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr (2008) 0.95
Should high-intensity-aerobic interval training become the clinical standard in heart failure? Heart Fail Rev (2013) 0.95
Exercise and life expectancy. Lancet (2012) 0.94
The impact of achieving perfect care in acute coronary syndrome: the role of computer assisted decision support. Am Heart J (2012) 0.94
Metabolic syndrome and heart failure--the risk, paradox, and treatment. Curr Hypertens Rep (2011) 0.93
Promoting health and wellness in the workplace: a unique opportunity to establish primary and extended secondary cardiovascular risk reduction programs. Mayo Clin Proc (2013) 0.93
Magnetised thermo responsive lipid vehicles for targeted and controlled lung drug delivery. Pharm Res (2012) 0.93
A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men. Mayo Clin Proc (2011) 0.93
Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care (2013) 0.92
Five-nanometer diamond with luminescent nitrogen-vacancy defect centers. Small (2009) 0.92
The "obesity paradox": is smoking/lung disease the explanation? Chest (2008) 0.92
Clinical implications of left atrial enlargement: a review. Ochsner J (2009) 0.91